Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FEcal Transplant, a Hope to Eradicate Colonization of Patient Harboring eXtreme Drug Resistant Bacteria?

NCT03029078 is registered in ClinicalTrials.gov with Centre d'Investigation Clinique et Technologique 805 as lead sponsor.

NCT NCT03029078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03029078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FEcal Transplant, a Hope to Eradicate Colonization of Patient Harboring eXtreme Drug Resistant Bacteria?
Lead sponsor
Centre d'Investigation Clinique et Technologique 805
Phase
Phase 4
Overall status
Completed
Start date
November 1, 2014
Completion date
December 1, 2020
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial peritonitis, faeces smearing, microbial colonization